A leader in innovative medical devices, Pioneer Surgical Technology, Inc. announced the successful human implantation of its new biologic inter-body spacer. The nanOss-Cervical cage is made from mechanically robust nano-crystalline hydroxyapatite (HA) and functions as bone.

Hospitals in Beijing and Suzhou China performed the surgeries on patients scheduled for standard cervical fusion surgery using the nanOss-Cervical implant, bone graft material and anterior cervical plate.

The surgeries was performed by Dr. Hansen Yuan, Professor of Orthopaedic and Neurological Surgery, State University of New York Upstate Medical University, Syracuse, NY along with other Chinese surgeons. Dr. Yuan said that the nanOss-Cervical cage was handled and implanted similarly to PEEK (poly-ether-ether-ketone) cages, and was used in conjunction with routine rigid fixation. The benefit of nanOss technology to the patient is it is a safe, natural substance and is biocompatible.

The nanOss-Cervical cage is intended to facilitate spinal fusion procedures by simultaneously maintaining decompression and serving as a graft containment device in conjunction with traditional rigid fixation.

In less than a year from acquiring the nanOss technology, Pioneer's development teams have created the nanOss-Cervical cage for fusion procedures. Strength properties of materials made of nanOss technology are twice as strong as PEEK cages yet, being biologic, behave as if it were bone.

Pioneer Surgical Technology, Inc. is a dynamic medical device firm founded in 1992. Pioneer's focus on innovation has resulted in over 100 U.S. and Foreign patents with numerous patents pending." The company's comprehensive portfolio of CE or investigational motion preservation devices, vertebral spacers, cervical plating systems, and MIS and Mini-Open Rod systems include notable trade names such as NuBac, BacJac, Contact, IJAK, Clarity, SlimFuse, and Quantum. Pioneer entered the orthobiologics market with two acquisitions in 2007. Encelle, Inc., developed E-Matrix for tissue regeneration. Angstrom Medica, Inc. is the first company to obtain FDA approval for a nanotechnology device -- nanOss -- hydroxyapatite bone void filler. Pioneer's Orthopaedic, Spine, and Biologic divisions produce state of the art, cost-effective solutions for surgical procedures that have proven difficult or problematic for both surgeons and patients. Pioneer employs more than 260 people worldwide. For more information go to: http://www.pioneersurgical.com/

Back to HCB News

More Voices